DR. JOE LEIGH SIMPSON, MD
Medical Practice at 8 St, Miami, FL

License number
Florida J5904
Category
Medical Practice
Type
Obstetrics & Gynecology
Address
Address
1200 SW 8Th St, Miami, FL 33199
Phone
(305) 348-0570

Personal information

See more information about JOE LEIGH SIMPSON at radaris.com
Name
Address
Phone
Joe Simpson
4810 NW Highway 72 LOT 131, Arcadia, FL 34266
Joe Simpson
4725 50Th St W APT 1405, Bradenton, FL 34210
Joe Simpson
560 E Winnetka St, Hernando, FL 34442
Joe Simpson
407 Hayes St, Lake Placid, FL 33852
(863) 699-0805
Joe Simpson, age 48
815 Coldwater Creek Cir, Niceville, FL 32578
(850) 678-3981

Professional information

Joe Simpson Photo 1

Owner, Jjs Appraisals

Position:
Owner at JJS Appraisals
Location:
Miami/Fort Lauderdale Area
Industry:
Real Estate
Work:
JJS Appraisals - Owner Robert Bare & Associates Sep 1999 - May 2006 - Residential Real Estate Appraiser Shepherd Care Ministries Sep 1992 - Sep 1999 - Director of Development
Education:
University of Iowa 1979 - 1984
bachelor of science journalism, Journalism / Mass Comunications


Joe L Simpson Photo 2

Dr. Joe L Simpson, Miami FL - MD (Doctor of Medicine)

Specialties:
Obstetrics & Gynecology, Clinical Genetics
Address:
11200 SW 8Th St, Miami 33199
1200 SW 8Th St, Miami 33135
(305) 348-0570 (Phone)
6550 Fannin St SUITE 701, Houston 77030
(713) 789-3242 (Phone)
Certifications:
Clinical Genetics, 1982, Obstetrics & Gynecology, 2010
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Duke University
Graduated: 1968
Ny Hosp


Joe Simpson Photo 3

Servic Aduisor At Maritech

Position:
servic aduisor at maritech
Location:
Miami/Fort Lauderdale Area
Industry:
Maritime
Work:
maritech - servic aduisor


Joe Simpson Photo 4

Screening For Down Syndrome

US Patent:
2008003, Feb 14, 2008
Filed:
Mar 27, 2007
Appl. No.:
11/692115
Inventors:
Farideh Bischoff - Sugarland TX, US
Joe Simpson - Miami FL, US
Assignee:
BAYLOR COLLEGE OF MEDICINE - Houston TX
International Classification:
C12Q 1/68
US Classification:
435006000
Abstract:
The present disclosure describes methods for screening and identifying genomic sequences useful in estimating the risk of fetal aneuploidy, particularly trisomy 21. This disclosure also describes methods for utilizing such genomic sequences alone or to augment existing non-invasive diagnostics for Trisomy 21 and other aneuploidies.